Michael Bastasch

Michael Bastasch

UNVERIFIED PROFILE

Are you Michael Bastasch?   Register this Author

Register author
Michael Bastasch

Michael Bastasch

Publications by authors named "Michael Bastasch"

Are you Michael Bastasch?   Register this Author

10Publications

63Reads

11Profile Views

Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction.

Front Radiat Ther Oncol 2007 ;40:352-365

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Tex. , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000106046DOI Listing
September 2007

Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy.

Am J Clin Oncol 2007 Aug;30(4):395-400

Department of Radiology/Section of Radiation Oncology, Methodist Hospital and Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00000421-200708000-000
Publisher Site
http://dx.doi.org/10.1097/COC.0b013e318033728fDOI Listing
August 2007

Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.

J Urol 2006 Jun;175(6):2097-101; discussion 2101-2

Department of Radiology/Section of Radiation Oncology, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0022-5347(06)00306-5DOI Listing
June 2006

Primary mucinous adenocarcinoma of the thymus: a case report and review of the literature.

Arch Pathol Lab Med 2006 Feb;130(2):201-4

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9073, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2006)130[201:PMAOTT]2.0.CO;2DOI Listing
February 2006

Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer.

Am J Clin Oncol 2006 Feb;29(1):8-11

Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine and The Methodist Hospital, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000195099.26957.63DOI Listing
February 2006

Predictors of extracapsular extension and its radial distance in prostate cancer: implications for prostate IMRT, brachytherapy, and surgery.

Cancer J 2003 Nov-Dec;9(6):454-60

Department of Radiology, Section of Radiation Oncology, The Methodist Hospital, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00130404-200311000-00004DOI Listing
April 2004

IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease.

Int J Radiat Oncol Biol Phys 2003 May;56(1):184-91

Department of Radiation Oncology, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(03)00085-3DOI Listing
May 2003

Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function.

Int J Radiat Oncol Biol Phys 2002 Sep;54(1):101-6

Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine and Methodist Hospital, 6565 Fannin, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(02)02901-2DOI Listing
September 2002

Phase II trial of pyrazoloacridine in advanced non-small cell carcinoma of the lung--a Kansas Cancer Institute and Thompson Cancer Survival Center Study.

Invest New Drugs 2002 Aug;20(3):339-42

The Kansas Cancer Institute, University of Kansas Medical Center, Kansas City 66160-7353, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1016293527755DOI Listing
August 2002